{"id":"https://openalex.org/W2259871202","doi":"https://doi.org/10.1200/jco.2013.31.15_suppl.2014","title":"NCCTG (Alliance) N0572: A phase II trial of sorafenib and temsirolimus in recurrent glioblastoma (GBM) patients who progress following prior RT/temozolomide (TMZ) and VEGF inhibitors (VEGFi).","display_name":"NCCTG (Alliance) N0572: A phase II trial of sorafenib and temsirolimus in recurrent glioblastoma (GBM) patients who progress following prior RT/temozolomide (TMZ) and VEGF inhibitors (VEGFi).","publication_year":2013,"publication_date":"2013-05-20","ids":{"openalex":"https://openalex.org/W2259871202","doi":"https://doi.org/10.1200/jco.2013.31.15_suppl.2014","mag":"2259871202"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2013.31.15_suppl.2014","doi":"https://doi.org/10.1200/jco.2013.31.15_suppl.2014","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2013.31.15_suppl.2014","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5023657472","display_name":"Kurt A. Jaeckle","orcid":"https://orcid.org/0000-0002-7827-463X","observed_orcids":["https://orcid.org/0000-0002-7827-463X"]},"institutions":[{"id":"https://openalex.org/I4210146710","display_name":"Mayo Clinic in Florida","ror":"https://ror.org/03zzw1w08","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723","https://openalex.org/I4210146710"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kurt A. Jaeckle","raw_affiliation_strings":["Mayo Clinic, Jacksonville, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic, Jacksonville, FL","institution_ids":["https://openalex.org/I4210146710"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023905352","display_name":"David Schiff","orcid":"https://orcid.org/0000-0002-1896-2502","observed_orcids":["https://orcid.org/0000-0002-1896-2502","https://orcid.org/0000-0003-1561-9220"]},"institutions":[{"id":"https://openalex.org/I4210134211","display_name":"University of Virginia Medical Center","ror":"https://ror.org/046kb4y45","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799765794","https://openalex.org/I4210134211"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David Schiff","raw_affiliation_strings":["University of Virginia Medical Center, Charlottesville, VA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Virginia Medical Center, Charlottesville, VA","institution_ids":["https://openalex.org/I4210134211"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063029973","display_name":"S. Keith Anderson","orcid":"https://orcid.org/0000-0003-1542-9726","observed_orcids":["https://orcid.org/0000-0003-1542-9726"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"S. Keith Anderson","raw_affiliation_strings":["Mayo Clinic, Rochester, MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic, Rochester, MN","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017494786","display_name":"Evanthia Galanis","orcid":"https://orcid.org/0000-0001-8014-786X","observed_orcids":["https://orcid.org/0000-0001-8014-786X"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Evanthia Galanis","raw_affiliation_strings":["Mayo Clinic, Rochester, MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic, Rochester, MN","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037503098","display_name":"Philip J. Stella","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I174354714","display_name":"Trinity Health Michigan","ror":"https://ror.org/01w8eym62","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1304269903","https://openalex.org/I174354714"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Philip J. Stella","raw_affiliation_strings":["Saint Joseph Mercy Health System, Ann Arbor, MI"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Saint Joseph Mercy Health System, Ann Arbor, MI","institution_ids":["https://openalex.org/I174354714"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012465182","display_name":"Patrick J. Flynn","orcid":"https://orcid.org/0000-0001-6516-8021","observed_orcids":["https://orcid.org/0000-0001-6516-8021"]},"institutions":[{"id":"https://openalex.org/I4210120135","display_name":"Metro-Minnesota Community Oncology Research Consortium","ror":"https://ror.org/02vhx9606","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210120135"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Patrick J. Flynn","raw_affiliation_strings":["Metro Minnesota Community Clinical Oncology Program, St. Louis Park, MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Metro Minnesota Community Clinical Oncology Program, St. Louis Park, MN","institution_ids":["https://openalex.org/I4210120135"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015247761","display_name":"Jann Nagina Sarkaria","orcid":"https://orcid.org/0000-0001-7489-4885","observed_orcids":["https://orcid.org/0000-0001-7489-4885"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jann Nagina Sarkaria","raw_affiliation_strings":["Mayo Clinic, Rochester, MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic, Rochester, MN","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069689120","display_name":"Caterina Giannini","orcid":"https://orcid.org/0000-0003-2757-6782","observed_orcids":["https://orcid.org/0000-0003-2757-6782"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Caterina Giannini","raw_affiliation_strings":["Mayo Clinic, Rochester, MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic, Rochester, MN","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008832314","display_name":"Bradley James Erickson","orcid":"https://orcid.org/0000-0001-7926-6095","observed_orcids":["https://orcid.org/0000-0001-7926-6095"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bradley J. Erickson","raw_affiliation_strings":["Mayo Clinic, Rochester, MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic, Rochester, MN","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5034104319","display_name":"Jan C. Buckner","orcid":"https://orcid.org/0000-0002-8688-266X","observed_orcids":["https://orcid.org/0000-0002-8688-266X"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jan C Buckner","raw_affiliation_strings":["Mayo Clinic, Rochester, MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic, Rochester, MN","institution_ids":["https://openalex.org/I1330342723"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":5,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":4,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"31","issue":"15_suppl","first_page":"2014","last_page":"2014"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/recurrent-glioblastoma","display_name":"recurrent glioblastoma","score":0.9950000047683716},{"id":"https://openalex.org/keywords/sorafenib","display_name":"sorafenib","score":0.9940000176429749},{"id":"https://openalex.org/keywords/temsirolimus","display_name":"temsirolimus","score":1.0},{"id":"https://openalex.org/keywords/mtor-inhibitors","display_name":"mTOR inhibitors","score":0.6259999871253967},{"id":"https://openalex.org/keywords/raf-inhibitors","display_name":"RAF inhibitors","score":0.8289999961853027},{"id":"https://openalex.org/keywords/mapk-signaling","display_name":"MAPK signaling","score":0.5649999976158142},{"id":"https://openalex.org/keywords/pi3k-akt-mtor-pathway","display_name":"PI3K/AKT/mTOR pathway","score":0.8899999856948853},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.7379999756813049},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.6179999709129333},{"id":"https://openalex.org/keywords/treatment-related-toxicity","display_name":"treatment toxicity","score":0.5490000247955322},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.5220000147819519},{"id":"https://openalex.org/keywords/bevacizumab","display_name":"bevacizumab","score":0.6439999938011169},{"id":"https://openalex.org/keywords/temozolomide","display_name":"temozolomide","score":0.906000018119812},{"id":"https://openalex.org/keywords/radiotherapy","display_name":"radiotherapy","score":0.6869999766349792}],"concepts":[{"id":"https://openalex.org/C2776820818","wikidata":"https://www.wikidata.org/wiki/Q7699074","display_name":"Temsirolimus","level":5,"score":0.958328366279602},{"id":"https://openalex.org/C2777389519","wikidata":"https://www.wikidata.org/wiki/Q425088","display_name":"Temozolomide","level":3,"score":0.8676584959030151},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8501212000846863},{"id":"https://openalex.org/C2778695046","wikidata":"https://www.wikidata.org/wiki/Q421136","display_name":"Sorafenib","level":3,"score":0.6601253151893616},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.6399621963500977},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6048393845558167},{"id":"https://openalex.org/C2777802072","wikidata":"https://www.wikidata.org/wiki/Q413299","display_name":"Bevacizumab","level":3,"score":0.5659257769584656},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5409283638000488},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.4493728280067444},{"id":"https://openalex.org/C86554907","wikidata":"https://www.wikidata.org/wiki/Q285613","display_name":"PI3K/AKT/mTOR pathway","level":3,"score":0.44845953583717346},{"id":"https://openalex.org/C57074206","wikidata":"https://www.wikidata.org/wiki/Q14197552","display_name":"MAPK/ERK pathway","level":3,"score":0.4442555904388428},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.3790847361087799},{"id":"https://openalex.org/C509974204","wikidata":"https://www.wikidata.org/wiki/Q180507","display_name":"Radiation therapy","level":2,"score":0.29318052530288696},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.2860393226146698},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.2171991765499115},{"id":"https://openalex.org/C183713625","wikidata":"https://www.wikidata.org/wiki/Q5282002","display_name":"Discovery and development of mTOR inhibitors","level":4,"score":0.20811796188354492},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.16364946961402893},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.07608690857887268},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0},{"id":"https://openalex.org/C2778019345","wikidata":"https://www.wikidata.org/wiki/Q1148337","display_name":"Hepatocellular carcinoma","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2013.31.15_suppl.2014","doi":"https://doi.org/10.1200/jco.2013.31.15_suppl.2014","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2013.31.15_suppl.2014","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2562916117","https://openalex.org/W2782514367","https://openalex.org/W4249751132","https://openalex.org/W2138218580","https://openalex.org/W2118915687","https://openalex.org/W2269121410","https://openalex.org/W2536552580","https://openalex.org/W2114438728","https://openalex.org/W566773017","https://openalex.org/W57783008"],"abstract_inverted_index":{"2014":[0],"Background:":[1],"PFS6":[2,135,291],"is":[3],"low":[4],"(2.3%)":[5],"and":[6,21,24,51,58,87,99,154,212,261,293],"med":[7],"OS":[8,201,294],"brief":[9],"(4":[10],"mos)":[11],"for":[12,186,279],"recurrent":[13,287,304],"GBM":[14,75,288,305],"pts":[15,76,114,167,219,306],"who":[16,77,307],"progress":[17],"after":[18],"prior":[19,82,119],"RT/TMZ":[20],"bevacizumab":[22],"(Bev),":[23],"then":[25],"receive":[26],"non-Bev":[27,313],"containing":[28,314],"regimens":[29],"(Reardon":[30],"et":[31],"al,":[32],"Br":[33],"J":[34],"Canc":[35],"2012).":[36],"Following":[37],"VEGFi":[38,88],"exposure,":[39],"tumor":[40],"cell":[41],"resistance":[42],"potentially":[43],"may":[44],"result":[45],"from":[46,136],"activation":[47],"of":[48,171,302],"Ras/Raf/MEK/ERK":[49],"(MAPK)":[50],"PI3K/Akt/mTOR":[52],"signaling":[53],"pathways.":[54],"Temsirolimus":[55],"(mTOR":[56],"inhibitor)":[57,63],"sorafenib":[59,94],"(Raf,":[60],"PDGFR,":[61],"VEGFR":[62],"have":[64,223],"previously":[65],"shown":[66],"limited":[67],"single":[68],"agent":[69],"activity":[70],"in":[71,134,239,285],"GBM.":[72],"Methods:":[73],"Recurrent":[74],"showed":[78],"radiographic":[79],"progression":[80],"despite":[81],"surgery,":[83],"RT":[84],"+":[85],"temozolomide,":[86],"(initially":[89],"or":[90],"at":[91],"recurrence)":[92],"received":[93,116],"200":[95],"mg":[96,102],"PO":[97],"bid":[98],"temsirolimus":[100,271],"20":[101],"IV":[103],"weekly":[104],"(the":[105],"NCCTG":[106],"N0572":[107],"phase":[108],"I":[109],"MTD)":[110],"until":[111],"progression.":[112,267],"All":[113],"had":[115],"<":[117],"2":[118],"chemo":[120],"regimens.":[121],"A":[122],"two-stage":[123],"design":[124],"was":[125,147,158,190,202,272,282],"used,":[126],"with":[127,311],"90%":[128],"power":[129],"to":[130,138,259,265,299],"detect":[131],"an":[132],"increase":[133],"8%":[137],"23%,":[139],"requiring":[140],"41":[141],"evaluable":[142,166],"pts.":[143],"The":[144],"primary":[145,276],"endpoint":[146,277],"PFS6;":[148],"secondary":[149],"endpoints":[150],"included":[151],"OS,":[152],"TTP,":[153],"ORR.":[155],"Toxicity":[156],"(TOX)":[157],"assessed":[159],"using":[160],"CTC":[161],"ver":[162],"3.0.":[163],"Results:":[164],"44":[165],"were":[168,216,237],"accrued.":[169],"Four":[170],"the":[172,183,275],"first":[173],"40":[174],"(10%)":[175,292],"reached":[176],"PFS6,":[177],"but":[178,274],"this":[179],"did":[180],"not":[181,224,283],"meet":[182],"pre-study":[184],"threshold":[185,278],"success.":[187],"Median":[188],"TTP":[189],"1.8":[191],"mos.":[192,204],"(40":[193],"events,":[194,206],"95%":[195,207],"CI:":[196,208],"1.5":[197],"\u2013":[198,210],"2.3);":[199],"median":[200],"5":[203],"(36":[205],"6.6":[209],"3.1),":[211],"no":[213],"objective":[214],"responses":[215],"reported.":[217],"Eight":[218],"are":[220,308],"alive;":[221],"4":[222,248],"progressed":[225],"(median":[226],"F/U":[227],"3.1":[228],"mos.;":[229],"max,":[230],"12.2":[231],"mos.).":[232],"Grade":[233],"3+":[234],"non-heme":[235],"AE":[236,250],"observed":[238],"51%":[240],"(23/45;":[241],"fatigue-5,":[242],"hypophosphatemia-7,":[243],"hypercholesterolemia-5,":[244],"hypertriglyceridemia-5).":[245],"One":[246],"grade":[247],"hematologic":[249],"(thrombocytopenia)":[251],"occurred.":[252],"13.3%":[253],"(6/45":[254],"pts)":[255],"went":[256],"off":[257],"due":[258,264],"TOX,":[260],"71.1%":[262],"(32/45)":[263],"disease":[266],"Conclusions:":[268],"Sorafenib":[269],"plus":[270],"tolerable,":[273],"success":[280],"(PFS6)":[281],"met":[284],"post-VEGFi":[286],"patients.":[289],"Nevertheless,":[290],"(5":[295],"mos.)":[296],"compared":[297],"favorably":[298],"contemporary":[300],"series":[301],"Bev-refractory,":[303],"subsequently":[309],"treated":[310],"a":[312],"regimen.":[315],"Supported":[316],"by":[317],"NCI":[318],"CA-25224.":[319],"Clinical":[320],"trial":[321],"information:":[322],"NCT00329719.":[323]},"counts_by_year":[{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}